Top Markets
#1 EXOD EXOD +56.80%
#2 MowCat MowCat +48.13%
#3 CoW Protocol CoW Protocol +44.52%
#4 Glidr Glidr +36.87%
#5 Walrus Walrus +25.11%
#6 Humanity Humanity +23.63%
#7 Enso Enso +19.41%
#8 Codatta Codatta +18.73%
#9 Collector Crypt Collector Crypt +14.19%
#10 The Black Bull The Black Bull +12.76%
Coin of the day
EXOD EXOD
Settings
Language
ENGLISH
Currency
USD
Theme
Carmell Therapeutics Corporation Carmell Therapeutics Corporation

Carmell Therapeutics Corporation

CTCX
Rank in Stocks #36666
Carmell Therapeutics Corporation (CTCX) specializes in the creation of... Carmell Therapeutics Corporation (CTCX) specializes in the creation of plasma-based bioactive materials (PBMs) aimed at catalyzing tissue regeneration and repair following injury, illness, or the effects of aging. Their flagship product, CT-101, is a versatile accelerant with a dual focus. For orthopedic and dental applications, it's designed to enhance bone healing in cases such as tibia fractures, foot and ankle fusions, spinal fusions, and also serves as a dental bone graft substitute and bone void filler. Furthermore, CT-101 acts as a tissue healing accelerant, addressing conditions like androgenetic alopecia (pattern baldness) and persistent chronic wounds. Established in 2008, the company operates from its headquarters in Pittsburgh, Pennsylvania.
Share Price
$0.117
Last synced: 2025-04-04
Market Cap
$2.45M
Change (1 day)
-13.59%
Change (1 year)
0.00%
Country
US
Trade Carmell Therapeutics Corporation (CTCX)

Category

Healthcare
EPS for Carmell Therapeutics Corporation (CTCX)
EPS as of June 2026 TTM: $-4.71
According to Carmell Therapeutics Corporation latest financial reports and stock price the company's current EPS (TTM) is $-4.71. At the end of 2023 the company had a EPS of $-0.74 an increase over its 2022 EPS that were of $-0.50.
EPS history for Carmell Therapeutics Corporation from 2021 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-4.71 842.00%
2024 $-0.50 -32.43%
2023 $-0.74 48.00%
2022 $-0.50 4,487.16%
2021 $-0.01 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -467.73%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -688.96%
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -390.87%
BE